Oncolytic Virus Encoding a Master Pro-Inflammatory Cytokine Interleukin 12 in Cancer Immunotherapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oncolytic Virus Encoding a Master Pro-Inflammatory Cytokine Interleukin 12 in Cancer Immunotherapy
Authors
Keywords
-
Journal
Cells
Volume 9, Issue 2, Pages 400
Publisher
MDPI AG
Online
2020-02-12
DOI
10.3390/cells9020400
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Two roads for oncolytic immunotherapy development
- (2019) Howard L. Kaufman et al. Journal for ImmunoTherapy of Cancer
- Eradication of glioblastoma by immuno-virotherapy with a retargeted oncolytic HSV in a preclinical model
- (2019) Francesco Alessandrini et al. ONCOGENE
- Targeting Angiogenesis in Prostate Cancer
- (2019) Zsombor Melegh et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Immunological Effects and Viral Gene Expression Determine the Efficacy of Oncolytic Measles Vaccines Encoding IL-12 or IL-15 Agonists
- (2019) Backhaus et al. Viruses-Basel
- The multi-receptor inhibitor axitinib reverses tumor-induced immunosuppression and potentiates treatment with immune-modulatory antibodies in preclinical murine models
- (2018) Heinz Läubli et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Combinatorial Effects of VEGFR Kinase Inhibitor Axitinib and Oncolytic Virotherapy in Mouse and Human Glioblastoma Stem-Like Cell Models
- (2018) Dipongkor Saha et al. CLINICAL CANCER RESEARCH
- Revisiting Interleukin-12 as a Cancer Immunotherapy Agent
- (2018) Pedro Berraondo et al. CLINICAL CANCER RESEARCH
- Oncolytic herpes simplex virus immunovirotherapy in combination with immune checkpoint blockade to treat glioblastoma
- (2018) Dipongkor Saha et al. Immunotherapy
- Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy
- (2018) Cheyne Kurokawa et al. JNCI-Journal of the National Cancer Institute
- HSV as A Platform for the Generation of Retargeted, Armed, and Reporter-Expressing Oncolytic Viruses
- (2018) Laura Menotti et al. Viruses-Basel
- Talimogene laherparepvec: First in class oncolytic virotherapy
- (2018) Robert M. Conry et al. Human Vaccines & Immunotherapeutics
- Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy
- (2018) Cheyne Kurokawa et al. JNCI-Journal of the National Cancer Institute
- Anti-Angiogenics: Current Situation and Future Perspectives
- (2018) Katja Zirlik et al. Oncology Research and Treatment
- Immune checkpoint inhibitors and cardiovascular toxicity
- (2018) Alexander R Lyon et al. LANCET ONCOLOGY
- Immune Checkpoint Inhibitor Toxicity
- (2018) David J. Palmieri et al. Current Oncology Reports
- Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression
- (2018) Gregory K. Friedman et al. Scientific Reports
- A fully-virulent retargeted oncolytic HSV armed with IL-12 elicits local immunity and vaccine therapy towards distant tumors
- (2018) Valerio Leoni et al. PLoS Pathogens
- Immune Checkpoint Inhibitor Toxicity in 2018
- (2018) Douglas B. Johnson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Tumor-conditional anti-CTLA4 uncouples antitumor efficacy from immunotherapy-related toxicity
- (2018) Chien-Chun Steven Pai et al. JOURNAL OF CLINICAL INVESTIGATION
- Oncolytic virus immunotherapy: future prospects for oncology
- (2018) Junaid Raja et al. Journal for ImmunoTherapy of Cancer
- Blockade of transforming growth factor-β signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma models
- (2017) Shinichi Esaki et al. INTERNATIONAL JOURNAL OF CANCER
- Optimized biodegradable polymeric reservoir-mediated local and sustained co-delivery of dendritic cells and oncolytic adenovirus co-expressing IL-12 and GM-CSF for cancer immunotherapy
- (2017) Eonju Oh et al. JOURNAL OF CONTROLLED RELEASE
- Rad51 Degradation: Role in Oncolytic Virus—Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy in Glioblastoma
- (2017) Jianfang Ning et al. JNCI-Journal of the National Cancer Institute
- Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143
- (2017) Antonio Omuro et al. NEURO-ONCOLOGY
- Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent
- (2017) Pengju Wang et al. Nature Communications
- Recurrent glioma clinical trial, CheckMate-143: the game is not over yet
- (2017) Anna C. Filley et al. Oncotarget
- Rad51 Degradation: Role in Oncolytic Virus—Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy in Glioblastoma
- (2017) Jianfang Ning et al. JNCI-Journal of the National Cancer Institute
- NK-Cell Recruitment Is Necessary for Eradication of Peritoneal Carcinomatosis with an IL12-Expressing Maraba Virus Cellular Vaccine
- (2017) Almohanad A. Alkayyal et al. Cancer Immunology Research
- Immune Checkpoint in Glioblastoma: Promising and Challenging
- (2017) Jing Huang et al. Frontiers in Pharmacology
- Oncolytic measles virus encoding interleukin-12 mediates potent antitumor effects through T cell activation
- (2017) Rūta Veinalde et al. OncoImmunology
- Newly Characterized Murine Undifferentiated Sarcoma Models Sensitive to Virotherapy with Oncolytic HSV-1 M002
- (2017) Eric K. Ring et al. Molecular Therapy-Oncolytics
- Oncolytic Viruses in Cancer Treatment
- (2017) Sean E. Lawler et al. JAMA Oncology
- Talimogene Laherparepvec (T-VEC) and Other Oncolytic Viruses for the Treatment of Melanoma
- (2016) Praveen K. Bommareddy et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma
- (2016) A. L. Ho et al. ANNALS OF ONCOLOGY
- Disease progression in recurrent glioblastoma patients treated with the VEGFR inhibitor axitinib is associated with increased regulatory T cell numbers and T cell exhaustion
- (2016) Stephanie Du Four et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model
- (2016) Adel Galal El-Shemi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- T-Cell Therapy Enabling Adenoviruses Coding for IL2 and TNFα Induce Systemic Immunomodulation in Mice With Spontaneous Melanoma
- (2016) Siri Tähtinen et al. JOURNAL OF IMMUNOTHERAPY
- Adenoviral Delivery of Tumor Necrosis Factor-α and Interleukin-2 Enables Successful Adoptive Cell Therapy of Immunosuppressive Melanoma
- (2016) Mikko Siurala et al. MOLECULAR THERAPY
- Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy/temozolomide for newly diagnosed glioblastoma
- (2016) Wolfgang Wick et al. NEURO-ONCOLOGY
- Recombinant Newcastle Disease Virus Encoding IL-12 and/or IL-2 as Potential Candidate for Hepatoma Carcinoma Therapy
- (2016) Guiping Ren et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Intratumoural interleukin 12 gene therapy stimulates the immune system and decreases angiogenesis in dogs with spontaneous cancer
- (2016) L. Cicchelero et al. Veterinary and Comparative Oncology
- IL-12 Expressing oncolytic herpes simplex virus promotes anti-tumor activity and immunologic control of metastatic ovarian cancer in mice
- (2016) Eric D. Thomas et al. Journal of Ovarian Research
- Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model
- (2016) Eonju Oh et al. Oncotarget
- Oncolytic herpes simplex virus interactions with the host immune system
- (2016) Dipongkor Saha et al. Current Opinion in Virology
- Effect of HSV-IL12 Loaded Tumor Cell-Based Vaccination in a Mouse Model of High-Grade Neuroblastoma
- (2016) David F. Bauer et al. Journal of Immunology Research
- Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma
- (2016) Daxa M. Patel et al. Human Gene Therapy Clinical Development
- The transporter associated with antigen processing: a key player in adaptive immunity
- (2015) Sabine Eggensperger et al. BIOLOGICAL CHEMISTRY
- A phase II trial of second-line axitinib following prior antiangiogenic therapy in advanced hepatocellular carcinoma
- (2015) Mairéad G. McNamara et al. CANCER
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
- (2015) Padmanee Sharma et al. CELL
- Exploring the antitumor effect of virus in malignant glioma
- (2015) DRUGS OF THE FUTURE
- Safety and antitumor effect of oncolytic and helper-dependent adenoviruses expressing interleukin-12 variants in a hamster pancreatic cancer model
- (2015) J Poutou et al. GENE THERAPY
- Talimogene laherparepvec (T-VEC) for the treatment of advanced melanoma
- (2015) Douglas B Johnson et al. Immunotherapy
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
- (2015) Christina Twyman-Saint Victor et al. NATURE
- Effect of Renal Impairment on the Pharmacokinetics and Safety of Axitinib
- (2015) Ying Chen et al. Targeted Oncology
- Virotherapy with a Semliki Forest Virus–Based Vector Encoding IL12 Synergizes with PD-1/PD-L1 Blockade
- (2015) José I. Quetglas et al. Cancer Immunology Research
- Axitinib increases the infiltration of immune cells and reduces the suppressive capacity of monocytic MDSCs in an intracranial mouse melanoma model
- (2015) Stephanie Du Four et al. OncoImmunology
- Preclinical toxicology of oncolytic adenovirus-mediated cytotoxic and interleukin-12 gene therapy for prostate cancer
- (2015) Svend O Freytag et al. Molecular Therapy-Oncolytics
- Designing herpes viruses as oncolytics
- (2015) Cole Peters et al. Molecular Therapy-Oncolytics
- Combination of Oncolytic Herpes Simplex Viruses Armed with Angiostatin and IL-12 Enhances Antitumor Efficacy in Human Glioblastoma Models
- (2015) Wei Zhang et al. NEOPLASIA
- Interleukin 12: still a promising candidate for tumor immunotherapy?
- (2014) Witold Lasek et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Strict Requirement for Vector-Induced Type I Interferon in Efficacious Antitumor Responses to Virally Encoded IL12
- (2014) I. Melero et al. CANCER RESEARCH
- New insights into IL-12-mediated tumor suppression
- (2014) S Tugues et al. CELL DEATH AND DIFFERENTIATION
- Antiangiogenic Therapy for Glioblastoma: Current Status and Future Prospects
- (2014) T. T. Batchelor et al. CLINICAL CANCER RESEARCH
- A Phase 1 Trial of Oncolytic HSV-1, G207, Given in Combination With Radiation for Recurrent GBM Demonstrates Safety and Radiographic Responses
- (2014) James M Markert et al. MOLECULAR THERAPY
- Treatment of orthotopic malignant peripheral nerve sheath tumors with oncolytic herpes simplex virus
- (2014) Slawomir Antoszczyk et al. NEURO-ONCOLOGY
- Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Pediatric Solid Tumors
- (2014) Michael L. Megison et al. PLoS One
- IL-12 Directs Further Maturation of Ex Vivo Differentiated NK Cells with Improved Therapeutic Potential
- (2014) Dorit Lehmann et al. PLoS One
- Evaluation of the Safety and Biodistribution of M032, an Attenuated Herpes Simplex Virus Type 1 Expressing hIL-12, After Intracerebral Administration to Aotus Nonhuman Primates
- (2014) Justin C. Roth et al. Human Gene Therapy Clinical Development
- HSV-1 ICP0: An E3 Ubiquitin Ligase That Counteracts Host Intrinsic and Innate Immunity
- (2014) Mirna Perusina Lanfranca et al. Cells
- Efficacy of oncolytic adenovirus expressing suicide genes and interleukin-12 in preclinical model of prostate cancer
- (2013) S O Freytag et al. GENE THERAPY
- Angiogenesis in Glioblastoma
- (2013) Sunit Das et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Neuroblastoma
- (2013) Lauren A. Gillory et al. PLoS One
- Multifaceted oncolytic virus therapy for glioblastoma in an immunocompetent cancer stem cell model
- (2013) T. A. Cheema et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanisms of Glioma-Associated Neovascularization
- (2012) Matthew E. Hardee et al. AMERICAN JOURNAL OF PATHOLOGY
- Combination of vinblastine and oncolytic herpes simplex virus vector expressing IL-12 therapy increases antitumor and antiangiogenic effects in prostate cancer models
- (2012) B J Passer et al. CANCER GENE THERAPY
- Oncolytic Virus Therapy for Glioblastoma Multiforme
- (2012) Guido Wollmann et al. CANCER JOURNAL
- Randomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant Prostate Cancer: CALGB 90401
- (2012) William Kevin Kelly et al. JOURNAL OF CLINICAL ONCOLOGY
- Preclinical Evaluation of a Genetically Engineered Herpes Simplex Virus Expressing Interleukin-12
- (2012) J. M. Markert et al. JOURNAL OF VIROLOGY
- Immunotherapeutic Synergy Between Anti-CD137 mAb and Intratumoral Administration of a Cytopathic Semliki Forest Virus Encoding IL-12
- (2012) José I Quetglas et al. MOLECULAR THERAPY
- Anti-angiogenic gene therapy in the treatment of malignant gliomas
- (2012) NaTosha N. Gatson et al. NEUROSCIENCE LETTERS
- Combined Therapy with Cytokine-Induced Killer Cells and Oncolytic Adenovirus Expressing IL-12 Induce Enhanced Antitumor Activity in Liver Tumor Model
- (2012) Zhi Yang et al. PLoS One
- HSV-1 ICP0: paving the way for viral replication
- (2011) Miles C Smith et al. Future Virology
- Strengthening of antitumor immune memory and prevention of thymic atrophy mediated by adenovirus expressing IL-12 and GM-CSF
- (2011) K-J Choi et al. GENE THERAPY
- Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rβ2 or IL-18Rα
- (2011) I-K Choi et al. GENE THERAPY
- ICP34.5 Protein of Herpes Simplex Virus Facilitates the Initiation of Protein Translation by Bridging Eukaryotic Initiation Factor 2α (eIF2α) and Protein Phosphatase 1
- (2011) Yapeng Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Novel Combination Treatment of Armed Oncolytic Adenovirus Expressing IL-12 and GM-CSF with Radiotherapy in Murine Hepatocarcinoma
- (2011) Wonwoo KIM et al. JOURNAL OF RADIATION RESEARCH
- Optimizing DC Vaccination by Combination With Oncolytic Adenovirus Coexpressing IL-12 and GM-CSF
- (2011) Song-Nan Zhang et al. MOLECULAR THERAPY
- Activation of Cytotoxic and Regulatory Functions of NK Cells by Sindbis Viral Vectors
- (2011) Tomer Granot et al. PLoS One
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- IL-12 Suppresses Vascular Endothelial Growth Factor Receptor 3 Expression on Tumor Vessels by Two Distinct IFN-γ–Dependent Mechanisms
- (2010) Elizabeth W. Sorensen et al. JOURNAL OF IMMUNOLOGY
- Semliki Forest virus-mediated gene therapy of the RG2 rat glioma
- (2010) F. P. Roche et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
- (2010) M. A. Curran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- “Armed” oncolytic herpes simplex viruses for brain tumor therapy
- (2010) Tomoki Todo Cell Adhesion & Migration
- Efficacy and Safety of Axitinib in Patients With Advanced Non–Small-Cell Lung Cancer: Results From a Phase II Study
- (2009) Joan H. Schiller et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma
- (2009) Neil N. Senzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Increased eIF2 Phosphorylation Attenuates Replication of Herpes Simplex Virus 2 vhs Mutants in Mouse Embryonic Fibroblasts and Correlates with Reduced Accumulation of the PKR Antagonist ICP34.5
- (2009) K. M. Wylie et al. JOURNAL OF VIROLOGY
- Treatment of Pancreatic Cancer With an Oncolytic Adenovirus Expressing Interleukin-12 in Syrian Hamsters
- (2009) Sergia Bortolanza et al. MOLECULAR THERAPY
- Therapeutic and Tumor-specific Immunity Induced by Combination of Dendritic Cells and Oncolytic Adenovirus Expressing IL-12 and 4-1BBL
- (2009) Jing-Hua Huang et al. MOLECULAR THERAPY
- Nonclinical Antiangiogenesis and Antitumor Activities of Axitinib (AG-013736), an Oral, Potent, and Selective Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases 1, 2, 3
- (2008) D. D. Hu-Lowe et al. CLINICAL CANCER RESEARCH
- Herpes simplex virus NV1020 as a novel and promising therapy for hepatic malignancy
- (2008) Kaitlyn J Kelly et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Construction of a Fully Retargeted Herpes Simplex Virus 1 Recombinant Capable of Entering Cells Solely via Human Epidermal Growth Factor Receptor 2
- (2008) L. Menotti et al. JOURNAL OF VIROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now